P2X7 Receptor Antagonist Market: Can Antagonists Revolutionize...

toegevoegd een audio Health

2026-07-01 07:40:30 -

P2X7 Receptor Antagonist Market: Can Antagonists Revolutionize Depression Treatment Through Neuroimmune Modulation?

Depression-targeted P2X7 antagonism — the JNJ-54175446 clinical trial in major depressive disorder using total sleep deprivation as a behavioral challenge model representing the most innovative psychiatric application in the global P2X7 market — creates the most commercially intriguing CNS indication expansion, with the P2X7 Receptor Antagonist Market reflecting depression...

0 Reacties 0 aandelen 6 Views 0 voorbeeld